H. Yokoyama

发表

Gender differences on MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) neurotoxicity in C57BL/6 mice

H. Kato, T. Araki, Masanori Ookubo, 2009, Molecular and Cellular Endocrinology.

Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice

H. Kato, T. Araki, Masanori Ookubo, 2008, Molecular and Cellular Endocrinology.

Neurotoxin 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP)-Induced Animal Models of Parkinson’s Disease

J. Kasahara, Yu Zhou, H. Yokoyama, 2017 .

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine) neurotoxicity in mice

J. Kasahara, H. Kato, T. Araki, 2010, Metabolic Brain Disease.

Therapeutic effect of a novel anti-parkinsonian agent zonisamide against MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine)neurotoxicity in mice

J. Kasahara, H. Kato, T. Araki, 2010, Metabolic Brain Disease.

Visceral Fat Obesity Contributes to the Tortuosity of the Thoracic Aorta on Chest Radiograph in Poststroke Japanese Patients

M. Kurabayashi, H. Yokoyama, Y. Oyama, 2006, Angiology.

Poly(ADP‐ribose)polymerase inhibitor can attenuate the neuronal death after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in mice

H. Kato, T. Araki, H. Yokoyama, 2009, Journal of neuroscience research.

A Novel Anti-Parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice

H. Kato, T. Araki, H. Yokoyama, 2009, Journal of Molecular Neuroscience.

A Novel Anti-Parkinsonian Agent, Zonisamide, Attenuates MPTP-Induced Neurotoxicity in Mice

H. Kato, T. Araki, H. Yokoyama, 2009, Journal of Molecular Neuroscience.

Stretch-induced Hypertrophic Growth of Cardiocytes and Processing of Brain-type Natriuretic Peptide Are Controlled by Proprotein-processing Endoprotease Furin*

T. Kanda, R. Nagai, H. Yokoyama, 1997, The Journal of Biological Chemistry.

Long‐term changes in the ipsilateral substantia nigra after transient focal cerebral ischaemia in rats

H. Kato, T. Araki, H. Yokoyama, 2010, International journal of experimental pathology.

Dopamine signaling negatively regulates striatal phosphorylation of Cdk5 at tyrosine 15 in mice

R. Kaji, J. Kasahara, S. Goto, 2013, Front. Cell. Neurosci..

A CASE OF LEFT ADRENAL ALDOSTERONOMA AND DUPLICATED INFERIOR VENA CAVA : INVERSE BLOOD FLOW IN THE LEFT VENA CAVA AFFECING ALDOSTERONE CONCENTRATION IN THE LEFT RENAL VEIN

H. Yokoyama, K. Murata, F. Naganuma, 1995 .

H. Kato, T. Araki, H. Yokoyama, 2008, Experimental and molecular pathology.

Neuropharmacological approach against MPTP (1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine)-induced mouse model of Parkinson's disease.

J. Kasahara, T. Araki, H. Yokoyama, 2011, Acta neurobiologiae experimentalis.

Role of glial cells in neurotoxin-induced animal models of Parkinson’s disease

J. Kasahara, T. Araki, H. Yokoyama, 2011, Neurological Sciences.

Comparative pharmacological study of free radical scavenger, nitric oxide synthase inhibitor, nitric oxide synthase activator and cyclooxygenase inhibitor against MPTP neurotoxicity in mice

H. Kato, T. Araki, H. Yokoyama, 2008, Metabolic Brain Disease.

Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease

T. Araki, H. Yokoyama, Ryohei Yano, 2008, Neurological Sciences.

Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice

H. Kato, T. Araki, H. Yokoyama, 2008, Journal of Neural Transmission.

Chronic Administration with Rotenone does not Enhance MPTP Neurotoxicity in C57BL/6 Mice

H. Kato, T. Araki, H. Yokoyama, 2010, Journal of Molecular Neuroscience.

Systemic Administration of Proteasome Inhibitor Protects Against MPTP Neurotoxicity in Mice

H. Kato, T. Araki, H. Yokoyama, 2009, Cellular and Molecular Neurobiology.

Neurotoxin 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Induced Animal Models for Parkinson's Disease

J. Kasahara, H. Yokoyama, M. Nomoto, 2013 .

Mirtazapine has a therapeutic potency in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mice model of Parkinson’s disease

J. Kasahara, H. Yokoyama, Akie Tanabe, 2014, BMC Neuroscience.

Cyclin-dependent kinase 5 with phosphorylation of tyrosine 15 residue is enriched in striatal matrix compartment in adult mice

J. Kasahara, W. Sako, S. Goto, 2011, Neuroscience.

Biochemical alterations of the striatum in an MPTP-treated mouse model of Parkinson’s disease

H. Kato, T. Araki, H. Yokoyama, 2010, Metabolic Brain Disease.

Delayed Treatment with Arundic Acid Reduces the MPTP-induced Neurotoxicity in Mice

H. Kato, T. Araki, H. Yokoyama, 2008, Cellular and Molecular Neurobiology.

Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.

H. Kato, T. Araki, H. Yokoyama, 2009, Experimental and molecular pathology.

Effects of estrogens on striatal damage after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in male and female mice

H. Kato, T. Araki, Masanori Ookubo, 2008, Molecular and Cellular Endocrinology.

Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.

H. Kato, T. Araki, H. Yokoyama, 2009, Experimental and molecular pathology.